No Inequitable Conduct In $41M Lens Suit: Judge

Law360, New York (September 29, 2008, 12:00 AM EDT) -- Nearly eight months after a jury arrived at a $41 million verdict against Novartis AG unit CIBA Vision Corp. for violating a contact lens patent held by Rembrandt Vision Technologies LP, a federal judge has rejected CIBA's inequitable conduct defense and found the patent to be enforceable.

Magistrate Judge Charles Everingham IV of the U.S. District Court for the Eastern District of Texas ruled Friday that the patent owners, husband and wife research team Dr. Sing-Hsiung Chang and Mei-Zyh Chang, did not commit inequitable conduct by...
To view the full article, register now.